References
- D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006;44:217–31.
- Groszmann RJ, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Planas R, Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 2005;353:2254–61.
- Garcia-Tsao G, Groszmann RJ, Fisher RL, Conn HO, Atterbury CE, Glickman M. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 1985;5:419–24.
- Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology 2007;133:481–8.
- Ripoll C, Banares R, Rincon D, Catalina MV, Lo Iacono O, Salcedo M, Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era. Hepatology 2005;42:793–801.
- Albillos A, Banares R, Gonzalez M, Ripoll C, Gonzalez R, Catalina MV, Value of the hepatic venous pressure gradient to monitor drug therapy for portal hypertension: a meta-analysis. Am J Gastroenterol 2007;102:1116–26.
- D'Amico G, Garcia-Pagan JC, Luca A, Bosch J. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology 2006;131:1611–24.
- Freeman RB Jr, Wiesner RH, Harper A, McDiarmid SV, Lake J, Edwards E, The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 2002;8:851–8.
- Merion RM, Wolfe RA, Dykstra DM, Leichtman AB, Gillespie B, Held PJ. Longitudinal assessment of mortality risk among candidates for liver transplantation. Liver Transpl 2003;9:12–18.
- Bambha K, Kim WR, Kremers WK, Therneau TM, Kamath PS, Wiesner R, Predicting survival among patients listed for liver transplantation: an assessment of serial MELD measurements. Am J Transplant 2004;4:1798–804.
- Giannini EG, Risso D, Caglieris S, Testa R. Longitudinal modifications of the MELD score have prognostic meaning in patients with liver cirrhosis. J Clin Gastroenterol 2005;39:912–14.
- Huo TI, Wu JC, Lin HC, Lee FY, Hou MC, Lee PC, Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score. J Hepatol 2005;42:826–32.
- Choi PC, Kim HJ, Choi WH, Park DI, Park JH, Cho YK, Model for end-stage liver disease, model for end-stage liver disease-sodium and Child-Turcotte-Pugh scores over time for the prediction of complications of liver cirrhosis. Liver Int 2009;29:221–6.
- Groszmann RJ, Wongcharatrawee S. The hepatic venous pressure gradient: anything worth doing should be done right. Hepatology 2004;39:280–2.
- Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005;42:1208–36.
- von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (strobe) statement: Guidelines for reporting observational studies. Lancet 2007;370:1453–7.
- Ripoll C, Groszmann RJ, Garcia-Tsao G, Bosch J, Grace N, Burroughs A, Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis. J Hepatol 2009;50:923–8.
- Villanueva C, Aracil C, Colomo A, Hernandez-Gea V, Lopez-Balaguer JM, Alvarez-Urturi C, Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding. Gastroenterology 2009;137:119–28.
- Merkel C, Bolognesi M, Berzigotti A, Amodio P, Cavasin L, Casarotto IM, Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria. J Hepatol 2010;52:45–53.